CWI1-2 HCL is a potent IGF2BP2 inhibitor, which binds IGF2BP2 and inhibits its interaction with M6A-modified target transcription, induces apoptosis and differentiation, and can be used in the study of the treatment of leukemia.
- Size: 1mg
- Purity: ≥98%
- Molecular Formula: C 2 2 H 1 8 Cl 4 N 6 O 3
- Molecular Weight: 556.23
- Physical State: Light yellow to yellow Solid
- Storage: Powder:2-8℃, 2 years;Insolvent(Mother Liquid):-20℃, 6 months;-80℃, 1 year
- Brand: Saint Michael
- Catalogue No.: ICA12840-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review